Chemoinformaics analysis of 9-Deoxygoniopypyrone
Molecular Weight | 234.251 | nRot | 1 |
Heavy Atom Molecular Weight | 220.139 | nRig | 7 |
Exact Molecular Weight | 234.089 | nRing | 3 |
Solubility: LogS | -1.917 | nHRing | 2 |
Solubility: LogP | 1.637 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 13 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 34.2531 |
nHD | 1 | BPOL | 18.3849 |
QED | 0.602 |
Synth | 1.341 |
Natural Product Likeliness | -0.445 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.002 |
HIA | 0.003 |
CACO-2 | -4.38 |
MDCK | 0.0000272 |
BBB | 0.733 |
PPB | 0.686086 |
VDSS | 0.748 |
FU | 0.274169 |
CYP1A2-inh | 0.971 |
CYP1A2-sub | 0.944 |
CYP2c19-inh | 0.842 |
CYP2c19-sub | 0.711 |
CYP2c9-inh | 0.207 |
CYP2c9-sub | 0.794 |
CYP2d6-inh | 0.04 |
CYP2d6-sub | 0.832 |
CYP3a4-inh | 0.042 |
CYP3a4-sub | 0.349 |
CL | 7.715 |
T12 | 0.83 |
hERG | 0.089 |
Ames | 0.138 |
ROA | 0.098 |
SkinSen | 0.217 |
Carcinogencity | 0.771 |
EI | 0.991 |
Respiratory | 0.149 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.647664 |